Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.

PubWeight™: 2.67‹?› | Rank: Top 1%

🔗 View Article (PMC 2192547)

Published in J Exp Med on May 01, 1996

Authors

M R Weiser1, J P Williams, F D Moore, L Kobzik, M Ma, H B Hechtman, M C Carroll

Author Affiliations

1: Department of Surgery, Harvard Medical School, Boston, Massachusetts 02115, USA.

Associated clinical trials:

RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function | NCT03791476

Articles citing this

How dying cells alert the immune system to danger. Nat Rev Immunol (2008) 8.63

The sterile inflammatory response. Annu Rev Immunol (2010) 3.45

The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol (2007) 3.12

The inflammatory response to cell death. Annu Rev Pathol (2008) 2.85

Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest (2000) 2.45

Identification of the target self-antigens in reperfusion injury. J Exp Med (2006) 2.38

Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A (2004) 2.30

The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest (1997) 2.28

Complement activation after oxidative stress: role of the lectin complement pathway. Am J Pathol (2000) 1.86

Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res (2008) 1.80

Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovasc Res (2010) 1.78

The alternative complement pathway revisited. J Cell Mol Med (2008) 1.62

Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol (2003) 1.49

Lymphocytes and ischemia-reperfusion injury. Transplant Rev (Orlando) (2009) 1.38

Identification of the cellular sensor that stimulates the inflammatory response to sterile cell death. J Immunol (2010) 1.36

TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm (2010) 1.32

The role of complement in the early immune response to transplantation. Nat Rev Immunol (2012) 1.26

Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin. Am J Physiol Heart Circ Physiol (2009) 1.22

New concepts in antibody-mediated immunity. Infect Immun (2004) 1.19

Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. Infect Immun (2007) 1.17

IgM contributes to glomerular injury in FSGS. J Am Soc Nephrol (2013) 1.17

Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury. Circulation (2015) 1.16

Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol (2004) 1.16

Complement in ischemia reperfusion injury. Am J Pathol (2003) 1.15

The complement system in ischemia-reperfusion injuries. Immunobiology (2012) 1.10

Complement activation promotes muscle inflammation during modified muscle use. Am J Pathol (2000) 1.07

Null mutation of gp91phox reduces muscle membrane lysis during muscle inflammation in mice. J Physiol (2003) 1.06

Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle. J Immunol (2005) 1.06

Molecular mechanisms of inflammation and tissue injury after major trauma--is complement the "bad guy"? J Biomed Sci (2011) 1.04

Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice. J Immunol (2011) 1.02

New concepts of complement in allorecognition and graft rejection. Cell Immunol (2007) 1.02

Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice. J Immunol (2013) 1.02

B cells limit repair after ischemic acute kidney injury. J Am Soc Nephrol (2010) 1.01

Innate response to self-antigen significantly exacerbates burn wound depth. Proc Natl Acad Sci U S A (2007) 1.00

The inflammatory response after an epidermal burn depends on the activities of mouse mast cell proteases 4 and 5. J Immunol (2010) 0.95

IgM colocalises with complement and C reactive protein in infarcted human myocardium. J Clin Pathol (2005) 0.95

Sca-1 influences the innate immune response during skeletal muscle regeneration. Am J Physiol Cell Physiol (2010) 0.93

Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner. J Biol Chem (2013) 0.92

Expression of complement components and inhibitors on platelet microparticles. Platelets (2008) 0.92

Alloimmune activation enhances innate tissue inflammation/injury in a mouse model of liver ischemia/reperfusion injury. Am J Transplant (2010) 0.91

Attenuation of the effects of rat hemorrhagic shock with a reperfusion injury-inhibiting agent specific to mice. Shock (2009) 0.91

B cells contribute to ischemia/reperfusion-mediated tissue injury. J Autoimmun (2009) 0.90

Complement receptors and the shaping of the natural antibody repertoire. Springer Semin Immunopathol (2004) 0.90

Beta-glucan enhances complement-mediated hematopoietic recovery after bone marrow injury. Blood (2005) 0.89

Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions. Clin Exp Immunol (2006) 0.88

Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy. J Am Soc Nephrol (2015) 0.88

Pathways to acute humoral rejection. Am J Pathol (2004) 0.87

Mannan-binding lectin-associated serine protease 2 is critical for the development of renal ischemia reperfusion injury and mediates tissue injury in the absence of complement C4. FASEB J (2014) 0.87

Complement inhibition as a proposed neuroprotective strategy following cardiac arrest. Mediators Inflamm (2010) 0.87

Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation. J Immunol (2010) 0.86

Theodore E. Woodward Award: antiphospholipid syndrome revisited: a disorder initiated by inflammation. Trans Am Clin Climatol Assoc (2007) 0.86

Complement activation by apoptotic endothelial cells following hypoxia/reoxygenation. Immunology (2001) 0.86

The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis. Fibrogenesis Tissue Repair (2014) 0.86

Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver. Clin Exp Immunol (2001) 0.85

Complement factor 3 deficiency attenuates hemorrhagic shock-related hepatic injury and systemic inflammatory response syndrome. Am J Physiol Regul Integr Comp Physiol (2010) 0.85

Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris. Immunology (2000) 0.83

Which pathways trigger the role of complement in ischaemia/reperfusion injury? Front Immunol (2012) 0.83

Natural antibodies and complement modulate intimal thickening after arterial injury. Am J Physiol Regul Integr Comp Physiol (2009) 0.83

Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x. Br J Pharmacol (1999) 0.83

The role of the complement system in acute kidney injury. Semin Nephrol (2013) 0.83

Heme interacts with c1q and inhibits the classical complement pathway. J Biol Chem (2011) 0.82

Monoclonal antibodies against peptidorhamnomannans of Scedosporium apiospermum enhance the pathogenicity of the fungus. PLoS Negl Trop Dis (2010) 0.82

Evaluation of the contribution of multiple DAMPs and DAMP receptors in cell death-induced sterile inflammatory responses. PLoS One (2014) 0.81

Acidosis activates complement system in vitro. Mediators Inflamm (1998) 0.81

TLR9 is dispensable for intestinal ischemia/reperfusion-induced tissue damage. Am J Clin Exp Immunol (2012) 0.81

Inhibition of rat gut reperfusion injury with an agent developed for the mouse. Evidence that amplification of injury by innate immunity is conserved between two animal species. Am J Physiol Regul Integr Comp Physiol (2010) 0.80

IgM in the kidney: a multiple personality disorder. Kidney Int (2015) 0.79

Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction. Biomed Res Int (2013) 0.79

Maternal Creatine Supplementation during Pregnancy Prevents Long-Term Changes in Diaphragm Muscle Structure and Function after Birth Asphyxia. PLoS One (2016) 0.79

Analysis of differential immune responses induced by innate and adaptive immunity following transplantation. Immunology (2003) 0.79

CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent. J Immunol (2010) 0.78

Emerging Functions of Natural IgM and Its Fc Receptor FCMR in Immune Homeostasis. Front Immunol (2016) 0.78

Restoration of skeletal muscle ischemia-reperfusion injury in humanized immunodeficient mice. Surgery (2009) 0.78

Helicobacter infection alters MyD88 and Trif signalling in response to intestinal ischaemia-reperfusion. Exp Physiol (2010) 0.77

Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury. Clin Immunol (2014) 0.77

Human β2-glycoprotein I attenuates mouse intestinal ischemia/reperfusion induced injury and inflammation. Mol Immunol (2012) 0.77

C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage. PLoS One (2013) 0.77

Acute Liver Injury Is Independent of B Cells or Immunoglobulin M. PLoS One (2015) 0.77

Mannan binding lectin-associated serine protease-2 (MASP-2) critically contributes to post-ischemic brain injury independent of MASP-1. J Neuroinflammation (2016) 0.77

Mouse mast cell proteases 4 and 5 mediate epidermal injury through disruption of tight junctions. J Immunol (2014) 0.77

The Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion Injury. PLoS One (2016) 0.76

Cell membrane modification for rapid display of bi-functional peptides: a novel approach to reduce complement activation. Open Cardiovasc Med J (2010) 0.76

Inhibition of complement activation by recombinant Sh-CRIT-ed1 analogues. Immunology (2003) 0.76

Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury. J Immunol (2012) 0.76

Ischemia-reperfusion injury and anesthesia. Biomed Res Int (2014) 0.75

Injury site-specific targeting of complement inhibitors for treating stroke. Immunol Rev (2016) 0.75

Resolvin D1 Alleviates the Lung Ischemia Reperfusion Injury via Complement, Immunoglobulin, TLR4, and Inflammatory Factors in Rats. Inflammation (2016) 0.75

Natural IgM Blockade Limits Infarct Expansion and Left Ventricular Dysfunction in a Swine Myocardial Infarct Model. Circ Cardiovasc Interv (2016) 0.75

Accommodation and related conditions in vascularized composite allografts. Curr Opin Organ Transplant (2017) 0.75

Soft-tissue damage during total knee arthroplasty: Focus on tourniquet-induced metabolic and ionic muscle impairment. J Orthop (2017) 0.75

Placental C4d deposition is a feature of defective placentation: observations in cases of preeclampsia and miscarriage. Virchows Arch (2015) 0.75

Ulk1-mediated autophagy plays an essential role in mitochondrial remodeling and functional regeneration of skeletal muscle. Am J Physiol Cell Physiol (2017) 0.75

Articles cited by this

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell (1992) 17.50

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science (1990) 4.67

Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A (1995) 4.33

Molecular organization and function of the complement system. Annu Rev Biochem (1988) 3.91

Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol (1993) 3.20

Membrane complement receptors specific for bound fragments of C3. Adv Immunol (1985) 2.80

Complement ligand-receptor interactions that mediate biological responses. Annu Rev Immunol (1983) 2.78

Fc receptors: rubor redux. Cell (1994) 2.77

Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families. J Immunol (1989) 1.88

Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol (1992) 1.84

Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol (1986) 1.83

Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest (1986) 1.81

Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest (1991) 1.48

Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation. Nature (1989) 1.37

Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear. Proc Natl Acad Sci U S A (1990) 1.35

Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J Immunol (1993) 1.26

Quantitative measurement of SC5b-9 and C5b-9(m) in infarcted areas of human myocardium. Clin Exp Immunol (1990) 1.20

Blockade of complement activation prevents local and pulmonary albumin leak after lower torso ischemia-reperfusion. Ann Surg (1992) 1.13

Role of selectins in local and remote tissue injury following ischemia and reperfusion. Am J Pathol (1994) 1.12

Characterization of anti-endothelial antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Rheumatol (1992) 1.00

Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis. Clin Immunol Immunopathol (1994) 0.97

Analysis of natural and disease-associated autoantibody repertoires: anti-endothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus. Int Immunol (1994) 0.97

Hypoxia induces endothelial cell synthesis of membrane-associated proteins. Proc Natl Acad Sci U S A (1991) 0.94

Salvage of postischemic skeletal muscle by monoclonal antibody blockade of neutrophil adhesion molecule CD18. J Surg Res (1994) 0.86

Natural (antiphospholipid-PDH,-DNA) autoantibodies and their physiologic serum inhibitors. Isr J Med Sci (1995) 0.84

Articles by these authors

Determination of Total Body Water and Solids With Isotopes. Science (1946) 7.43

The Use of Thiouracil in the Preparation of Patients With Hyperthyroidism for Thyroidectomy. Ann Surg (1944) 7.02

The structural basis of the multiple forms of human complement component C4. Cell (1984) 6.68

The Redistribution of Body Water and the Fluid Therapy of the Burned Patient. Ann Surg (1947) 6.18

A STUDY OF CAPILLARY PERMEABILITY IN EXPERIMENTAL BURNS AND BURN SHOCK USING RADIOACTIVE DYES IN BLOOD AND LYMPH. J Clin Invest (1944) 4.82

An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood (1996) 4.65

Hepatic--portal venous gas in adults: etiology, pathophysiology and clinical significance. Ann Surg (1978) 4.53

Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci U S A (1995) 4.33

EFFECT OF IODINE ON THE THYROID GLAND IN GRAVES' DISEASE WHEN GIVEN IN CONJUNCTION WITH THIOURACIL-A TWO-ACTION THEORY OF IODINE. J Clin Invest (1945) 4.27

Human C'3: evidence for the liver as the primary site of synthesis. Science (1969) 4.17

The two cultures and the health care revolution. Commerce and professionalism in medical care. JAMA (1997) 4.12

A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med (2000) 3.65

STUDIES WITH RADIOACTIVE DI-AZO DYES. II. THE SYNTHESIS AND PROPERTIES OF RADIOACTIVE DI-BROM TRYPAN BLUE AND RADIOACTIVE DI-BROM EVANS BLUE. J Clin Invest (1943) 3.60

A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys (1995) 3.53

Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A (2004) 3.45

A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med (1998) 3.32

A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature (1984) 3.27

Body Composition: Studies in the Human Being by the Dilution Principle. Science (1952) 3.27

High-cost users of medical care. N Engl J Med (1980) 3.19

Homotransplantation of the Canine Liver as an Orthotopic Vascularized Graft: Histologic and Functional Correlations During Residence in the New Host. Am J Pathol (1962) 3.14

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest (1999) 2.94

Complications and Mortality in Subtotal Gastrectomy for Duodenal Ulcer: Report on a Two-Stage Procedure. Ann Surg (1944) 2.85

Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem (1996) 2.82

Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci U S A (1985) 2.76

Improved thin-layer chromatographic method for the separation of major phospholipids and glycolipids from plant lipid extracts and phosphatidyl glycerol and bis(monoacylglyceryl) phosphate from animal lipid extracts. J Chromatogr (1977) 2.55

Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol (1996) 2.51

Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest (1999) 2.44

The Anemia of Thermal Burns. Ann Surg (1946) 2.39

Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab (1996) 2.33

Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30

Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity (1996) 2.29

Expeditious Care of Full-Thickness Burn Wounds by Surgical Excision and Grafting. Ann Surg (1947) 2.19

A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J Exp Med (1997) 2.19

Orthotopic autotransplantation and allotransplantation of the liver: functional and structural patterns in the dog. Ann Surg (1967) 2.17

Engineering salt-tolerant Brassica plants: characterization of yield and seed oil quality in transgenic plants with increased vacuolar sodium accumulation. Proc Natl Acad Sci U S A (2001) 2.13

Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol (1985) (1999) 2.13

Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region. EMBO J (1985) 2.09

Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J Exp Med (1999) 2.08

Low Temperature Development Induces a Specific Decrease in trans-Delta-Hexadecenoic Acid Content which Influences LHCII Organization. Plant Physiol (1987) 2.07

Moderation. Ann Surg (1967) 2.06

Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J Immunol (1995) 2.01

Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J Clin Invest (1986) 2.00

The effect of weight loss in overweight, lactating women on the growth of their infants. N Engl J Med (2000) 2.00

Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J (1987) 2.00

Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res (1995) 1.99

Primary alcohol sulfatase in a Pseudomonas species. Appl Microbiol (1965) 1.97

Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu Rev Immunol (2000) 1.95

Vagus Resection for Ulcer: An Interim Evaluation : II. Clinical Results. Ann Surg (1947) 1.95

Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol (1998) 1.95

The high cost of low-frequency events: the anatomy and economics of surgical mishaps. N Engl J Med (1981) 1.94

Metabolism of linear alcohols with various chain lengths by a Pseudomonas species. Appl Microbiol (1966) 1.94

Breast self-examination. N Engl J Med (1978) 1.93

In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A (1996) 1.90

A critical role for complement in maintenance of self-tolerance. Immunity (1998) 1.90

The Nature of the Shift of Plasma Protein to the Extravascular Space Following Thermal Trauma. Ann Surg (1948) 1.89

Reactive oxygen in skeletal muscle. I. Intracellular oxidant kinetics and fatigue in vitro. J Appl Physiol (1985) (1992) 1.87

Aortic aneurysm repair. Reduced operative mortality associated with maintenance of optimal cardiac performance. Ann Surg (1980) 1.85

Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol (1992) 1.84

Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med (1996) 1.83

Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and the C4B genes in the HLA class III region. Molecular cloning, exon-intron structure, composite retroposon, and breakpoint of gene duplication. J Biol Chem (1994) 1.82

Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem (1995) 1.80

Protective T cell-independent antiviral antibody responses are dependent on complement. J Exp Med (1999) 1.79

Structure and organization of the C4 genes. Philos Trans R Soc Lond B Biol Sci (1984) 1.78

Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature (1997) 1.78

Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol (1989) 1.77

Karyotypic Variation within Clonal Lineages of the Rice Blast Fungus, Magnaporthe grisea. Appl Environ Microbiol (1993) 1.75

Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proc Natl Acad Sci U S A (1989) 1.73

The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest (1998) 1.66

Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am J Pathol (1992) 1.65

Dielectrophoretic assembly of electrically functional microwires from nanoparticle suspensions. Science (2001) 1.65

Speciation of key arsenic metabolic intermediates in human urine. Anal Chem (2000) 1.65

The production, attrition, and biologic life-time of surgeons in relation to the population of the United States: a look into the future through the clouded computer crystal. Ann Surg (1972) 1.63

The route of antigen entry determines the requirement for L-selectin during immune responses. J Exp Med (1996) 1.61

Transrectal prostatic biopsy. Br Med J (1971) 1.60

Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science (1998) 1.59

Complement activation in factor D-deficient mice. Proc Natl Acad Sci U S A (2001) 1.59

Development at Cold-Hardening Temperatures : The Structure and Composition of Purified Rye Light Harvesting Complex II. Plant Physiol (1987) 1.59

Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation (2001) 1.58

Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene (2000) 1.58

The removal of water and nonlipid contaminants from lipid extracts. Lipids (1970) 1.58

Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect (2000) 1.58

Process analysis in outpatient knee surgery: effects of regional and general anesthesia on anesthesia-controlled time. Anesthesiology (2000) 1.57

Muscle surface pH as an index of peripheral perfusion in man. Ann Surg (1971) 1.57

Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. Am J Physiol (1996) 1.57

Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg (1991) 1.57

Cloning of a human complement component C4 gene. Proc Natl Acad Sci U S A (1983) 1.56

Blood volume measurement: a critical study prediction of normal values: controlled measurement of sequential changes: choice of a bedside method. Adv Surg (1965) 1.56

Torsion of intraabdominal testicular tumors. A case report. Cancer (1996) 1.56

HL7 document patient record architecture: an XML document architecture based on a shared information model. Proc AMIA Symp (1999) 1.55

A macrophage invasion mechanism of pathogenic mycobacteria. Science (1997) 1.55